FI884947L - Tetrahydro-furo- och tieno/2,3-c/ pyridiner, deras anvaendning saosom laekemedel och foerfarande foer deras framstaellning. - Google Patents

Tetrahydro-furo- och tieno/2,3-c/ pyridiner, deras anvaendning saosom laekemedel och foerfarande foer deras framstaellning. Download PDF

Info

Publication number: FI884947L
Authority: FI; Finland
Prior art keywords: och; deras; pyridiner; tieno; furo
Prior art date: 1987-10-29

Application number

FI884947A

Other languages

English (en)

Other versions

FI884947A0 (fi

FI884947A7 (fi

Inventor

Albrecht Harreus

Karl-Heinz Weber

Gerhard Walther

Werner Stransky

Franz Josef Kuhn

Guenter Schingnitz

Helmut Ensinger

Original Assignee

Boehringer Ingelheim Kg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-10-29

Filing date

1988-10-27

Publication date

1989-04-30

1988-10-27 Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg

1988-10-27 Publication of FI884947A0 publication Critical patent/FI884947A0/fi

1989-04-30 Publication of FI884947A7 publication Critical patent/FI884947A7/fi

1989-04-30 Publication of FI884947L publication Critical patent/FI884947L/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Ophthalmology & Optometry (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Psychiatry (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

FI884947A 1987-10-29 1988-10-27 Tetrahydro-furo- och tieno/2,3-c/ pyridiner, deras anvaendning saosom laekemedel och foerfarande foer deras framstaellning. FI884947L (fi)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19873736664 DE3736664A1 (de)	1987-10-29	1987-10-29	Tetrahydro-furo- und -thieno(2,3-c)pyridine, ihre verwendung als arzneimittel und verfahren zu ihrer herstellung

Publications (3)

Publication Number	Publication Date
FI884947A0 FI884947A0 (fi)	1988-10-27
FI884947A7 FI884947A7 (fi)	1989-04-30
FI884947L true FI884947L (fi)	1989-04-30

Family

ID=6339349

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI884947A FI884947L (fi)	1987-10-29	1988-10-27	Tetrahydro-furo- och tieno/2,3-c/ pyridiner, deras anvaendning saosom laekemedel och foerfarande foer deras framstaellning.

Country Status (17)

Country	Link
EP (1)	EP0314154A3 (fi)
JP (1)	JPH01157983A (fi)
KR (1)	KR890006650A (fi)
AU (1)	AU2443588A (fi)
CS (1)	CS273193B2 (fi)
DD (1)	DD283395A5 (fi)
DE (1)	DE3736664A1 (fi)
DK (1)	DK603588A (fi)
FI (1)	FI884947L (fi)
HU (1)	HU201553B (fi)
IL (1)	IL88184A0 (fi)
NO (1)	NO884835L (fi)
PL (1)	PL275555A1 (fi)
PT (1)	PT88899B (fi)
SU (1)	SU1657064A3 (fi)
YU (1)	YU201288A (fi)
ZA (1)	ZA888089B (fi)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2623810B2 (fr) *	1987-02-17	1992-01-24	Sanofi Sa	Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
US5272148A (en) *	1992-09-09	1993-12-21	Hoechst-Roussel Pharmaceuticals Incorporated	Heteroarenylpiperazines
US8914114B2 (en)	2000-05-23	2014-12-16	The Feinstein Institute For Medical Research	Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
WO2002004461A1 (en) *	2000-07-06	2002-01-17	Sankyo Company, Limited	Hydropyridine derivative acid addition salts
CA2476896A1 (en) *	2002-02-26	2003-09-04	North Shore-Long Island Jewish Research Institute	Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
US10912712B2 (en)	2004-03-25	2021-02-09	The Feinstein Institutes For Medical Research	Treatment of bleeding by non-invasive stimulation
EP1734941A2 (en)	2004-03-25	2006-12-27	The Feinstein Institute for Medical Research	Neural tourniquet
US11207518B2 (en)	2004-12-27	2021-12-28	The Feinstein Institutes For Medical Research	Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
CA2593079C (en)	2004-12-27	2014-08-19	North Shore-Long Island Jewish Research Institute	Treating inflammatory disorders by electrical vagus nerve stimulation
TWI392681B (zh) *	2006-04-06	2013-04-11	Daiichi Sankyo Co Ltd	高純度普拉格雷及其酸加成鹽之製法
MY151726A (en) *	2007-03-02	2014-06-30	Daiichi Sankyo Co Ltd	Process for production of prasugrel hydrochloride having high purity
WO2009029614A1 (en)	2007-08-27	2009-03-05	The Feinstein Institute For Medical Research	Devices and methods for inhibiting granulocyte activation by neural stimulation
WO2009146030A1 (en)	2008-03-31	2009-12-03	The Feinstein Institute For Medical Research	Methods and systems for reducing inflammation by neuromodulation of t-cell activity
US9662490B2 (en)	2008-03-31	2017-05-30	The Feinstein Institute For Medical Research	Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
US8996116B2 (en)	2009-10-30	2015-03-31	Setpoint Medical Corporation	Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
US9211410B2 (en)	2009-05-01	2015-12-15	Setpoint Medical Corporation	Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
EP2440284B1 (en)	2009-06-09	2018-09-12	Setpoint Medical Corporation	Nerve cuff with pocket for leadless stimulator
US11051744B2 (en)	2009-11-17	2021-07-06	Setpoint Medical Corporation	Closed-loop vagus nerve stimulation
US9833621B2 (en)	2011-09-23	2017-12-05	Setpoint Medical Corporation	Modulation of sirtuins by vagus nerve stimulation
EP2515996B1 (en)	2009-12-23	2019-09-18	Setpoint Medical Corporation	Neural stimulation devices and systems for treatment of chronic inflammation
CN103619405B (zh)	2011-05-09	2015-11-25	赛博恩特医疗器械公司	用于治疗慢性炎症的胆碱能抗炎通路的单个脉冲激活
US12172017B2 (en)	2011-05-09	2024-12-24	Setpoint Medical Corporation	Vagus nerve stimulation to treat neurodegenerative disorders
US9572983B2 (en)	2012-03-26	2017-02-21	Setpoint Medical Corporation	Devices and methods for modulation of bone erosion
US11311725B2 (en)	2014-10-24	2022-04-26	Setpoint Medical Corporation	Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
US11406833B2 (en)	2015-02-03	2022-08-09	Setpoint Medical Corporation	Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US10596367B2 (en)	2016-01-13	2020-03-24	Setpoint Medical Corporation	Systems and methods for establishing a nerve block
CN114904142A (zh)	2016-01-20	2022-08-16	赛博恩特医疗器械公司	迷走神经刺激的控制
WO2017127758A1 (en)	2016-01-20	2017-07-27	Setpoint Medical Corporation	Implantable microstimulators and inductive charging systems
US11471681B2 (en)	2016-01-20	2022-10-18	Setpoint Medical Corporation	Batteryless implantable microstimulators
US10583304B2 (en)	2016-01-25	2020-03-10	Setpoint Medical Corporation	Implantable neurostimulator having power control and thermal regulation and methods of use
US11173307B2 (en)	2017-08-14	2021-11-16	Setpoint Medical Corporation	Vagus nerve stimulation pre-screening test
US11260229B2 (en)	2018-09-25	2022-03-01	The Feinstein Institutes For Medical Research	Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
AU2020272128B9 (en)	2019-04-12	2025-11-20	Setpoint Medical Corporation	Vagus nerve stimulation to treat neurodegenerative disorders
EP4090424A4 (en)	2020-01-13	2024-02-21	The Feinstein Institutes for Medical Research	TREATMENT OF BLEEDING AND BLEEDING DISORDERS BY HIGH-INTENSITY FOCUSED ULTRASONIC STIMULATION OF THE SPLEEN
IL304787B2 (en)	2020-05-21	2025-12-01	Feinstein Institutes For Medical Research	Systems and methods for vagus nerve stimulation
US12444497B2 (en)	2021-05-17	2025-10-14	Setpoint Medical Corporation	Neurostimulation parameter authentication and expiration system for neurostimulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2315274A1 (fr) *	1975-06-27	1977-01-21	Parcor	Nouveaux derives de la thieno (2,3-c) pyridine, leur preparation et leurs applications
FR2317303A1 (fr) *	1975-07-09	1977-02-04	Parcor	Procede de preparation de derives de la tetrahydrothieno (3,2-c) et (2,3-c) pyridine

1987
- 1987-10-29 DE DE19873736664 patent/DE3736664A1/de not_active Withdrawn
1988
- 1988-10-27 FI FI884947A patent/FI884947L/fi not_active IP Right Cessation
- 1988-10-27 DD DD88321141A patent/DD283395A5/de not_active IP Right Cessation
- 1988-10-27 CS CS712688A patent/CS273193B2/cs unknown
- 1988-10-27 YU YU02012/88A patent/YU201288A/xx unknown
- 1988-10-27 IL IL88184A patent/IL88184A0/xx unknown
- 1988-10-28 HU HU885642A patent/HU201553B/hu not_active IP Right Cessation
- 1988-10-28 PL PL27555588A patent/PL275555A1/xx unknown
- 1988-10-28 DK DK603588A patent/DK603588A/da not_active Application Discontinuation
- 1988-10-28 NO NO88884835A patent/NO884835L/no unknown
- 1988-10-28 KR KR1019880014063A patent/KR890006650A/ko not_active Withdrawn
- 1988-10-28 PT PT88899A patent/PT88899B/pt not_active IP Right Cessation
- 1988-10-28 EP EP19880117961 patent/EP0314154A3/de not_active Withdrawn
- 1988-10-28 AU AU24435/88A patent/AU2443588A/en not_active Abandoned
- 1988-10-28 SU SU884356747A patent/SU1657064A3/ru active
- 1988-10-28 JP JP63272853A patent/JPH01157983A/ja active Pending
- 1988-10-28 ZA ZA888089A patent/ZA888089B/xx unknown

Also Published As

Publication number	Publication date
AU2443588A (en)	1989-07-13
EP0314154A3 (de)	1990-12-05
KR890006650A (ko)	1989-06-15
FI884947A0 (fi)	1988-10-27
CS712688A2 (en)	1990-06-13
DD283395A5 (de)	1990-10-10
HU201553B (en)	1990-11-28
JPH01157983A (ja)	1989-06-21
NO884835L (no)	1989-05-02
DE3736664A1 (de)	1989-05-11
PT88899B (pt)	1993-01-29
PL275555A1 (en)	1989-05-02
FI884947A7 (fi)	1989-04-30
CS273193B2 (en)	1991-03-12
ZA888089B (en)	1990-07-25
SU1657064A3 (ru)	1991-06-15
DK603588D0 (da)	1988-10-28
NO884835D0 (no)	1988-10-28
IL88184A0 (en)	1989-06-30
DK603588A (da)	1989-04-30
EP0314154A2 (de)	1989-05-03
YU201288A (en)	1990-08-31
HUT50824A (en)	1990-03-28

Publication	Publication Date	Title
FI884947L (fi)	1989-04-30	Tetrahydro-furo- och tieno/2,3-c/ pyridiner, deras anvaendning saosom laekemedel och foerfarande foer deras framstaellning.
FI884487A7 (fi)	1988-09-29	Katalysatorer, foerfarande foer deras framstaellning och anvaendning.
FI890094A0 (fi)	1989-01-09	Cylindrisk, nmr-biaseringsmagnetanordning utnyttjande permanenta magnetar och foerfarande foer densamma.
FI882690A7 (fi)	1988-12-09	Polyolefiner innehaollande funktionella grupper, maskerade monomerer innehaollande funktionella grupper, reaktionsblandningar och foerfaranden foer deras framstaellning.
FI880198A7 (fi)	1988-09-22	Vattenhaltiga blekmedelsuspensioner innehaollande peroxikarboxylsyror, foerfarande foer deras framstaellning och deras anvaendning.
FI881380L (fi)	1988-09-25	1,4-disubstituerade piperazinfoereningar, deras framstaellning och anvaendning.
FI881086L (fi)	1988-09-12	Olja-i-vatten-emulsioner, foerfarande foer deras framstaellning och deras anvaendning.
FI894566A7 (fi)	1989-09-27	Substituerade benzazepiner, deras framstaellning och dessa innehaollande farmaceutiska blandningar.
FI884886A0 (fi)	1988-10-21	Kaliumkarbonatbaerare, kaliumkatalyter och medelst dessa utfoerda olefindimeriseringsprocesser.
FI870546A0 (fi)	1987-02-10	1,4-bensoxazinderivat, deras framstaellning och anvaendning.
FI884505A0 (fi)	1988-09-30	Immunoanalys, i vilken anvaends igg-uppsnappande antikroppar och detekteringssystem foer flera monoklonala antikroppar.
FI871081A0 (fi)	1987-03-12	1,1-disubstituerade cyklopropanderivat, deras framstaellningsfoerfarande och anvaendning.
FI885592L (fi)	1989-06-02	Aryloxifenylpropylaminer, deras framstaellning och anvaendning.
FI885596A0 (fi)	1988-12-01	Manumycinderivat, foerfarande foer deras framstaellning och deras anvaendning.
FI880525L (fi)	1988-08-07	Substituerade aminderivat, deras framstaellning och anvaendning.
FI882442L (fi)	1988-11-27	Elledande belaeggningsmassa, foerfarande foer framstaellning och anvaendning daerav.
FI880199A7 (fi)	1988-09-22	Vattenhaltiga blekmedelsuspensioner innehaollande peroxikarboxylsyror, foerfarande foer deras framstaellning och deras anvaendning.
FI882715A0 (fi)	1988-06-08	Fenolderivat, deras framstaellning och anvaendning.
FI881609A7 (fi)	1988-10-10	Dihydropyridinamider, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
FI883986L (fi)	1989-03-01	Tricykliska fusionerade pyrimidinderivat, deras framstaellning och anvaendning.
FI884863A7 (fi)	1989-04-24	Kondenserade diazepinoner, foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel.
FI892949A0 (fi)	1989-06-15	2,5,6,7-tetranor-4,8-inter-m-fenylen -pg12-derivat, foerfarande foer dess framstaellning och dess anvaendning.
FI883812A7 (fi)	1989-02-21	4'-deshydroxiepipodofyllotoxin -glukosider, syntes och anvaendning.
FI884455L (fi)	1989-03-31	Renin-haemmande dipeptider, foerfarande foer deras framstaellning, dessa innehaollande laekemedel och deras anvaendning.
FI871448A7 (fi)	1987-10-06	Bis-tertiaerbutylaminosubstituerade 1,3,5-triazinderivat, foerfaranden foer deras framstaellning, dessa foereningar innehaollande laekemedel och deras anvaendning.

Legal Events

Date	Code	Title	Description
2004-08-31	MM	Patent lapsed	Owner name: BOEHRINGER INGELHEIM KG